A few other studies have further shown that MAP3K19 inhibition attenuated the profibrotic activity of these cells in vitro and in an adoptive transfer severe combined immunodeficiency (SCID) model of pulmonary fibrosis [5]. Here, MAP3K19 is linked to pulmonary fibrosis.